In 2023, the neoplasms mortality in the UK was below the forecasted figure for 2024. The data for 2024 onwards shows a year-on-year increase in male deaths, from 93.95 thousand in 2024 to 95.88 thousand in 2028. The compound annual growth rate (CAGR) over this forecasted period suggests a steady increase in mortality stats. A key consideration is the consistency in growth rate, which is modest yet persistent.

Future trends to monitor include:

Advancements in medical treatments and early detection that may influence mortality rates.
Policy changes and healthcare investments that could impact cancer care efficacy.
Demographic changes or lifestyle factors that may alter risk profiles.